The C-type lectin-like receptor CD161, which has recently been described to promote T cell expansion, is expressed on a discrete subset of human CD4 T cells. The function of such cells, however, has remained elusive. We now demonstrate that CD161 
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CD4 T cells that produce IL-17 (IL-17A) have been recognized as a Th cell lineage distinct from Th1 and Th2, termed Th17 ( 1 ). Th17 cells are critical mediators of destructive tissue infl ammation in several animal models of chronic infl ammation ( 2 ) . Cytokines typically produced by Th17 cells, such as IL-17, IL-17F, and IL-22, are also found in elevated levels in several human infl ammatory diseases ( 3 ) . Genetic evidence for a putative etiological link of Th17 with human disease emerged from the association of polymorphisms in the IL-23R to altered susceptibility to infl ammatory bowel disease (IBD), psoriasis, and ankylosing spondylitis ( 4 ) . The IL-23R can be expressed on a variety of cells ( 5 ) but is most characteristically associated with cells of the Th17 lineage ( 2, 6 ) . Recently, T cell clones displaying characteristics of Th17 cells could be propagated from disease-aff ected sites in psoriasis, rheumatoid arthritis, and Crohn ' s disease (CD) ( 7, 8 ) . Comparison of the Th17 clones with Th1 and Th2 clones obtained from the same infl ammatory infi ltrate confi rmed Th17-specifi c expr ession of factors such as IL-23R, the transcription factor ROR ␥ T, and the chemokine receptor CCR6. However, because in vitro -expanded T cell clones were analyzed, it has remained unclear how Th17 cells are involved in the disease process.
In addition to previously recognized Th17 hallmarks, analyses of such Th17 clones revealed specifi c expression of CD161 ( 9 ) . CD161 is a C-type lectin-like receptor that is also expressed on subsets of NK and CD8 T cells ( 10 ) . CD161 has been described as a coactivating receptor promoting antigen-dependent T cell proliferation upon engagement via its recently identifi ed CD161 + and CD161 Ϫ CD4 T memory cell subsets after FACS purifi cation (Fig. S1 D) confi rmed the fl ow cytometry results, revealing > 10-fold higher levels of il23r expression in CD161 + cells ( Fig. 1 B ) . In addition, CD161 + , as compared with CD161 Ϫ , CD4 T memory cells expressed 3 -10-fold higher levels of mRNA for IL-17 and IL-22 but not IFN-␥ ( Fig. 1 C ) . Consistent with their transcriptional Th17 signature, CD161 + CD4 T memory cells were the major source of IL-17 protein in the intestine ( Fig. 1 D ) .
CD161 + CD4 T cells can also be found in the circulation, where they comprise ‫ف‬ 20% of CD4 T lymphocytes, and, similar to the intestine, exhibit a memory phenotype ( 13 ) . According to a recent study, IL-17-production is attributed to such CD161 + CD4 T cells when compared with total CD161 Ϫ CD4 T cells ( 9 ) . To confi rm the Th17 nature of circulating CD161 + CD4 T cells, we selectively focused on CD25-depleted memory CD4 T cells to avoid enrichment for naive and regulatory T cells in the CD161 Ϫ fraction. Indeed, elevated levels of il17 , rorc , and il23r transcripts were found in CD161 + as compared with CD161 Ϫ CD4 + CD25 Ϫ CD45RA Ϫ T memory cells ( Fig. 1 E ) . Expression of commonly Th1-associated factors il12rb2 , ifng , and tbx21 (the gene encoding T-bet) did not diff er signifi cantly between the two subsets ( Fig. 1 E ) . A Th17 phenotype was also refl ected in the TCR-mediated cytokine production pattern of CD161 + CD4 T memory cells ( Fig. 1 F ) , indicating that circulating and gut-resident CD161 + CD4 T memory cells constitute a peripheral Th17 pool.
Tracking the phenotype of CD161 + CD4 T cells thus enabled us to follow the involvement of Th17 in CD infl ammation. We observed markedly increased IL-17 production in the blood of CD patients, which was confi ned to CD161 + cells ( Fig. 2 A ) . IFN-␥ -producing cells were present in similar levels in both T memory cell subsets ( Fig. 2 B ) . Cells expressing both IL-17 and IFN-␥ were only found among CD161 + CD4 T memory cells as a minor fraction, with no signifi cant diff erence between health and disease ( Fig. S2 , available at http://www.jem.org/cgi/content/full/ jem.20081712/DC1). The enhanced IL-17 production in CD161 + cells was accompanied by a signifi cant increase of IL-23R + cells ( Fig. 2 C ) . Culturing CD161 + CD4 T memory cells from normal or CD donors confi rmed their altered activation state during disease: TCR-mediated IL-17 and IL-22 but not IFN-␥ production was increased in CD161 + cells from CD patients ( Fig. 2 D ) . Addition of IL-23 induced a 1.6-fold median increase in IL-17 production and a 2.2-fold median increase in IFN-␥ production in CD patients while minimally aff ecting cytokine levels in healthy donors (1-and 1.2-fold, respectively; Fig. 2 E ) .
The distinct IL-23 responsiveness in purifi ed CD161 + cells from CD patients suggested that the infl ammatory microenvironment provides crucial cosignals for IL-23. Corroborating the notion of IL-1 ␤ , particularly, as an important co-stimulator of diff erentiated Th17 cells ( 20 ) , CD161 + CD4 T memory cells express higher levels of the IL-1 ␤ receptor IL-1R1 than their CD161 Ϫ counterparts in both ligand PILAR ( 11 ) . In adults, CD161 + CD4 T cells are present in the intestine and in the circulation of healthy people ( 12, 13 ) but were also found in rheumatic joints and psoriatic lesions ( 14, 15 ) . Recently, it was shown that CD161 + T cells from the infl ammatory infi ltrate in psoriasis and CD were enriched for IL-17 producers ( 9 ) . CD, one of the two most common forms of IBD, displays a particularly strong connection to Th17 infl ammation; genome-wide studies not only associated polymorphisms in the IL-23R with increased disease susceptibility but also single nucleotide polymorphisms in additional components of the Th17 pathway (i.e., stat3 , p40 , jak2 , and ccr6 ) ( 16 ) . CD is believed to be the result of an aberrant response of the gut-associated lymphoid tissue to bacterial and dietary antigen. Although the presence of Th17 cells in the infl amed intestine has been demonstrated ( 7 -9 ), their contribution to the disease process has remained elusive.
CD4 + T cells comprise the major lymphocyte subset in the normal intestinal lamina propria and mostly display a memory/eff ector phenotype ( 17 ) , with a discrete subset expressing CD161 ( 12, 18 ) . In light of the proposed link of CD161 with IL-17 -producing cells ( 9 ), we hypothesized that, similar to observations in mice ( 19 ) , a gut-resident Th17 population also exists in humans, and set out to (a) identify the physiological Th17 cell pool and (b) characterize the involvement of these infl ammatory cells in human disease. By examining surgical gut resections and blood specimens from CD patients and non-IBD controls, we identify the CD161 + population of CD4 T memory cells in the intestine and circulation to express hallmarks of the Th17 pathway (i.e., IL-23R, ROR ␥ T, IL-17, and CCR6). Furthermore, we defi ne their contribution to systemic and local infl ammation during CD, and demonstrate that these cells can be activated by IL-23 in an infl ammatory environment to release proinfl ammatory cytokines. Thus, our data show that CD161 + CD4 T cells comprise the physiological Th17 cell pool that can be activated by IL-23 during infl ammation.
RESULTS AND DISCUSSION
The intestine harbors a large fraction of the body ' s T cells. To investigate if the human intestinal T cells comprise a population of Th17 cells, as observed in mice, we isolated the lamina propria mononuclear cell (LPMC) fraction from freshly obtained normal adjacent colonic tissue derived from surgery for colorectal cancer or diverticulosis, and analyzed the T helper cell compartment. As expected, the majority of lamina propria CD4 T cells displayed a memory/eff ector phenotype (CD45RO + , CD45RA Ϫ ; SD = 73.4 ± 9.2%; Fig. S1 A, available at http://www.jem.org/cgi/content/full/jem.20081712/ DC1) and contained a signifi cant proportion of cells expressing CD161 (SD = 64.3 ± 12.1%; Fig. S1 B) . CD161 + CD4 T cells exclusively exhibit a memory/eff ector phenotype (CD45RO + , CD45RA Ϫ ; Fig. S1 C) . Analysis of the CD4 T cell compartment for IL-23R expression, a hallmark of Th17 cells, revealed that CD161 + CD4 T memory cells contained a higher frequency of cells positive for IL-23R than their negative counterparts ( Fig. 1 A ) . Transcriptional analysis of the BRIEF DEFINITIVE REPORT these eff ects nor did it induce proliferation by itself ( Fig. 3 D ) . To address whether the increase in cell number was responsible for the increased cytokine production after IL-1 ␤ stimulation, we measured the relative expression of il17 , ifng , and il22 genes, which is independent of cell number. The overall trend of cytokine transcript expression resembled the pattern of protein levels; if anything, the eff ect of IL-23, particularly, on IL-17 expression by IL-1 ␤ -primed CD161 + CD4 T cells was more pronounced on the transcriptional level (4.4-fold mean increase; healthy and CD donors ( Fig. 3 A ) . Stimulation of normal CD161 + CD4 T memory cells with IL-1 ␤ drove IL-17, IL-22, and IFN-␥ production, which was, particularly for IL-17 and IFN-␥ , further amplifi ed by the addition of IL-23 (2.4-and 1.8-fold mean increase, respectively; Fig. 3 B ) . In CD161 Ϫ CD4 T memory cells, co-stimulation with IL-1 ␤ and IL-23 failed to induce signifi cant levels of theses cytokines, underlining the unique responsiveness of CD161 + CD4 T memory cells to Th17-promoting signals.
To understand the basis of IL-1 ␤ and/or IL-23 actions, we assessed the eff ect on cell survival and proliferation. The rate of apoptosis was similar across all culture conditions (SD = 7.1 ± 1.7%; not depicted). In addition, there was no diff erence in the intrinsic proliferative capacity between CD161 + and CD161 Ϫ CD4 T memory cells ( Fig. 3 C ) . Addition of IL-1 ␤ , however, had a signifi cant though modest eff ect on the proliferation of CD161 + and, to a lesser extent, CD161 Ϫ CD4 T cells ( Fig. 3 D ) . Interestingly, IL-23 neither added to Having shown that CD161 + Th17 cells can be potently activated in an infl ammatory environment, we now explored their role in sustaining end-organ infl ammation, as defi ned by their potential to (a) migrate to the disease-aff ected sites and (b) induce local tissue infl ammation. Cell traffi cking from the blood into areas of active infl ammation requires the expression regulate it ( Fig. 4 B ) . Because surface expression of CCR6 has recently been attributed to Th17 cells ( 7, 23 ) , these results not only confi rm the infl ammatory potential but also the Th17 phenotype of CD161 + CD4 T memory cells.
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When primed by intestinal DCs, T cells up-regulate the gut homing receptor integrin ␤ 7 ( 24 ). CD161 + CD4 T cells from normal blood manifested a higher frequency of integrin ␤ 7 + cells than CD161 Ϫ T cells, indicating the intestine as their initial site of priming ( Fig. 4 C ) . Moreover, such integrin ␤ 7 + CD161 + CD4 T memory cells coexpressed integrin of the appropriate homing and chemokine receptors. In particular, the chemokine receptor CCR6 facilitates CD4 T memory cell traffi cking to epithelial sites ( 21 ) , and its sole chemokine ligand, CCL20 (MIP-3 ␣ ), is highly expressed at sites of CD infl ammation ( 22 ) . In healthy subjects, a mean of 67.9% ( ± 12.3% SD) of CD161 + CD4 T memory cells was positive for CCR6 as compared with 34.6% ( ± 12% SD) of their CD161 Ϫ counterparts ( Fig. 4 A ) . The proportion of CCR6 expression was not altered during disease: CD161 + cells maintained high expression of this receptor, whereas CD161 Ϫ cells failed to up- 
To investigate whether CD161 + T cells indeed contribute to CD infl ammation, we analyzed the composition of the intestinal infl ammatory infi ltrate. Mononuclear cell isolations from CD gut resections revealed a 20-fold increase of CD161 + CD4 T cells as compared with control specimens ( Fig. 4 F ) . Moreover, these CD161 expressers presented the predominant subset of infi ltrating CD4 T cells ( Fig. 4 G ) . Because the gut physiologically contains a high frequency of CD161 + CD4 T cells, we assessed these cells for phenotypical diff erences in health and disease. The frequency of intestinal integrin ␤ 7 + CD161 + CD4 T memory cells was dramatically increased during CD ( Fig. 4 H ) , consistent with the hypothesis that recirculating cells contribute to the increase in total numbers. Interestingly, all such integrin ␤ 7 + cells coexpressed CCR6, indicating the Th17 nature of the infi ltrate ( Fig. 4 H ) .
Th17-derived cytokines, including IL-17, IL-17F, and IL-22, have been shown to induce expression of infl ammatory mediators by intestinal cells ( 28 ) . Given the selective association ␣ 4 ( Fig. 4 C ) . Integrin ␤ 7, when in complex with integrin ␣ 4, binds the gut-specifi c mucosal addressin cellular adhesion molecule 1 (MAdCAM-1) ( 25 ) . During CD, MAdCAM-1 is up-regulated in the intestinal vasculature, potentiating the recruitment of integrin ␣ 4 ␤ 7 + cells to disease-aff ected sites ( 26 ) . In this context, it was intriguing that in CD patients the frequency of circulating integrin ␤ 7 + CD161 + CD4 T cells was notably decreased ( Fig. 4 D ) . The hereby suggested sequestration of such cells in the intestine was supported by another fi nding: CD161 + CD4 T memory cells from healthy donors presented a higher per cell ratio of integrin ␤ 7 than CD161 Ϫ cells ( Fig. 4 E ) . In CD patients, however, the remaining integrin ␤ 7 expressers displayed a signifi cant reduction in the mean fl uorescent intensity of integrin ␤ 7 staining ( Fig. 4 E ) . It has been previously reported that binding to MAdCAM-1 is favored by dense expression of integrin ␤ 7 ( 27 ) , indicating that integrin ␤ 7 bright CD161 + CD4 T cells preferentially partition to the intestine during disease. the Th2-specifi c prostaglandin receptor CRTh2, illustrate the complexity of lineage-controlling signals ( 30 ) . The identifi cation of CD161, a C-type lectin-like receptor with homology to CD69, points at additional co-stimulatory pathways in the Th17 response: the role of CD161 in supporting activationinduced T cell expansion paired with its selective expression on Th17 cells could potentially make it an attractive therapeutic target in CD and other related diseases.
MATERIALS AND METHODS
Patients and blood donors. Fresh colon specimens were obtained from patients undergoing surgery for CD or noninfl ammatory diseases such as colorectal cancer or diverticulosis from the University of Michigan (reviewed and approved by the University of Michigan Institutional Review Board), the Cooperative Human Tissue Network at Vanderbilt University (reviewed and approved by Independent Review Consulting), or Asterand (all studies through which Asterand acquires human tissue specimens are approved and overseen by either local or central institutional review boards, and are reviewed by Asterand ' s Quality Assurance Department). All samples were collected from surplus surgical material with fully informed patient consent. Tissues were reexamined by a pathologist. Blood was obtained from CD patients and healthy individuals scheduled for a routine colonoscopy at the Mayo Clinic (approved by the Mayo Clinic Institutional Review Board), as well as healthy adult volunteer donors participating in the Stanford Medical School Blood Center blood donation program, in accordance with the Declaration of Helsinki. For CD samples, patients with a known history of CD were enrolled, and activity at the time of blood draw was assessed by colonoscopy, followed by pathological examination of biopsies.
Isolation of mononuclear cells. LPMCs were isolated from surgical colon resections according to an established protocol ( 31 ) modifi ed to not exceed 6 h. In brief, isolated mucosa was incubated in HBSS-CMF containing 3 mM ␤ ME to dissolve mucus, followed by repeated incubations with 5 mM EDTA in HBSS-CMF to dissociate the epithelial layer. Washed lamina propria was then cut into small pieces and digested during repeated incubations in collagenase and DNase containing complete RPMI 1640 at 37 ° C in a shaking water bath. Cells were used for FACS analysis and gene expression profi ling or cultured overnight, and the nonadherent cell fraction was further processed for T cell subset purifi cation. LPMCs were cultured overnight and the nonadherent cell fraction was further processed. PBMCs were isolated as previously described ( 6 ) . Cytokine measurement and assessment of viability. IFN-y, IL-17, IL-22, CXCL5, and CXCL8 were measured using Quantikine kits (R & D Systems). An IL-17F electrochemiluminescence assay was developed in-house for the of CD161 + CD4 T cells with the gut, we then asked whether these cells were particularly biased toward inducing intestinal tissue infl ammation. Treatment of HT-29 colon epithelial cells with supernatant from IL-1 ␤ -and IL-23 -activated CD161 + cells compared with CD161 Ϫ cells led to increased expression of CXCL5, CXCL8, and CCL20, chemokines known to sustain the infl ammatory process during CD ( Fig. 5 A ) . CD161 + CD4 T cell -induced chemokine expression was signifi cantly reduced after neutralization of IL-22 and, in the case of CCL20, IL-17 activity, and reached levels similar to CD161 Ϫ T cell -induced expression ( Fig. 5 B ) . Interestingly, neither recombinant IL-17 or IL-22, nor the combination of both, was suffi cient to induce detectable levels of any of those factors (unpublished data). Thus, our results demonstrate that Th17 cytokines defi ne the infl ammatory potential of CD161 + CD4 T cells but that these molecules have to act in concert with the infl ammatory microenvironment. The even broader implication of CD161 + CD4 T cells in mediating the infl ammatory response became evident when we analyzed another cell type, 18Co intestinal myofi broblasts, for their response to activation with T cell supernatant: in addition to CCL20, these cells also expressed elevated levels of IL-6 and TNF-␣ , two key mediators of tissue destruction in CD ( Fig. 5 C ) .
In conclusion, we have identifi ed a CD161-expressing subpopulation of circulating and gut-resident CD4 T memory cells with a unique ability to respond to IL-23 to become fully diff erentiated/activated Th17 cells, and demonstrate their central involvement in chronic target-organ infl ammation (Fig. S4 , available at http://www.jem.org/cgi/content/full/ jem.20081712/DC1). Recently, Cosmi et al. isolated CD161 + CD4 T cells from umbilical cord blood as well as postnatal thymus, and demonstrated their early commitment to the Th17 lineage ( 9 ) . It is conceivable that these cells present precursors of the herein described CD161 + T memory cell population, which during the development of the immune system mature and as precommitted CD161 + Th17 cells selectively partition to the intestine, where they eventually present a distinct Th cell subset. Devoid of an infl ammatory environment, these CD161 + T cells are protected from the critical impact of IL-23 activation. Introduction of infl ammatory stimuli, however, releases this inhibition: a single, potent proinfl ammatory cytokine (IL-1 ␤ ) was able to license purifi ed CD161 + CD4 memory cells for activation by IL-23. Importantly, CD161 + T cells isolated from CD patients ' blood displayed an enhanced Th17 phenotype and were capable of responding to IL-23 in the absence of any infl ammatory co-stimulus. It will be interesting to decipher whether this indicated an in situ activation before isolation or rather a disease-specifi c intrinsic defect leading to inappropriate IL-23 responsiveness.
The factors involved in Th cell diff erentiation and in shaping their eff ector functions leave a lineage-specifi c fi ngerprint on the surface. In these regards, phenotypical characterization of cytokine and chemokine receptor expression has been instrumental in defi ning Th cell subsets and understanding their biology. In addition, the diff erential expression of TIM family members on Th1 and Th2 cells ( 29 ) , as well as Gene expression profi ling. RNA was isolated from cell pellets and gene expression was profi led by quantitative RT-PCR (qRT-PCR), as previously described ( 6 ) . The absence of genomic DNA contamination was confi rmed using primers recognizing genomic DNA in the cd4 promoter region. Gene expression data were normalized to the expression of ubiquitin ( UBB ).
Statistical analysis. For two-group comparisons, the Mann-Whitney ranksum test or the Wilcoxon signed-rank test was used. One way analysis of variance was performed using the Kruskal-Wallis statistics test or the Friedman test, both followed by Dunn ' s post test.
Online supplemental material. Fig. S1 depicts fl ow cytometric analysis of LPMCs showing that the majority of colonic CD4 T cells express CD45RO and CD161. Fig. S2 shows that the small proportion of IL-17 and IFN-␥ double producers in the circulation is contained within the CD161 + CD4 T memory cell compartment. Fig. S3 shows the x-fold increase of IL-1 ␤ -induced cytokine transcript or protein expression by CD161 + Th17 cells after stimulation with IL-23. 
